Astera Labs, Inc. (NASDAQ:ALAB) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Astera Labs, Inc. (NASDAQ:ALAB) has been given an average rating of “Moderate Buy” by the twenty-four brokerages that are covering the firm, Marketbeat.com reports. Nine investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating on the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $229.65.

Several research analysts have weighed in on ALAB shares. Loop Capital started coverage on Astera Labs in a research report on Thursday, March 5th. They set a “buy” rating and a $250.00 price target on the stock. UBS Group started coverage on Astera Labs in a research report on Tuesday, April 21st. They set a “neutral” rating and a $180.00 price target on the stock. TD Cowen boosted their price target on Astera Labs from $140.00 to $225.00 and gave the stock a “hold” rating in a research report on Wednesday. Citigroup boosted their price target on Astera Labs from $200.00 to $245.00 and gave the stock a “buy” rating in a research report on Wednesday. Finally, Weiss Ratings raised Astera Labs from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday.

Insider Activity at Astera Labs

In other Astera Labs news, Director Manuel Alba sold 183,000 shares of the firm’s stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $107.61, for a total transaction of $19,692,630.00. Following the completion of the sale, the director owned 319,863 shares of the company’s stock, valued at $34,420,457.43. This trade represents a 36.39% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 10,000 shares of the firm’s stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $107.77, for a total value of $1,077,700.00. Following the sale, the general counsel directly owned 118,084 shares of the company’s stock, valued at $12,725,912.68. This represents a 7.81% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,064,888 shares of company stock worth $150,764,723 in the last three months. 12.50% of the stock is owned by company insiders.

Institutional Investors Weigh In On Astera Labs

Hedge funds have recently added to or reduced their stakes in the business. Assetmark Inc. lifted its holdings in Astera Labs by 374.1% during the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after purchasing an additional 101 shares during the last quarter. Reflection Asset Management acquired a new stake in Astera Labs during the 4th quarter valued at $25,000. Smartleaf Asset Management LLC lifted its holdings in Astera Labs by 422.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after purchasing an additional 152 shares during the last quarter. Hilltop National Bank lifted its holdings in Astera Labs by 100.0% during the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after purchasing an additional 100 shares during the last quarter. Finally, Aventura Private Wealth LLC acquired a new stake in Astera Labs during the 4th quarter valued at $33,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Stock Up 2.1%

NASDAQ:ALAB opened at $199.79 on Tuesday. The firm has a market capitalization of $34.25 billion, a price-to-earnings ratio of 134.99, a price-to-earnings-growth ratio of 3.30 and a beta of 3.35. Astera Labs has a twelve month low of $69.26 and a twelve month high of $262.90. The stock’s 50 day moving average price is $143.77 and its two-hundred day moving average price is $153.99.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.07. The firm had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business’s quarterly revenue was up 93.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, analysts anticipate that Astera Labs will post 1.48 earnings per share for the current year.

More Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: JPMorgan raised its price target on Astera Labs to $280 from $205 and kept an overweight rating, signaling strong confidence in further upside after the company’s latest results. Benzinga
• Positive Sentiment: Needham lifted its price target to $260, while other reports cited positive forecasts from JPMorgan and Stifel, adding to the bullish analyst momentum around ALAB. Astera Labs (NASDAQ:ALAB) Price Target Raised to $260.00 at Needham & Company LLC
• Positive Sentiment: Commentary around the stock highlighted Astera Labs as a long-term momentum name and a beneficiary of AI connectivity demand, suggesting investors see durable growth tied to datacenter buildouts and server interconnect products. Why Astera Labs, Inc. (ALAB) is a Top Momentum Stock for the Long-Term
• Positive Sentiment: Several pieces emphasized strong AI connectivity demand and Scorpio expansion, with upbeat takes on the company’s positioning in the datacenter market helping support the stock. Nuts and Bolts AI Play Gains Momentum: Astera Labs Targets Raised
• Neutral Sentiment: Post-earnings analysis was mixed: bulls pointed to strong growth, but critics noted rising costs, competition, and a premium valuation, which could cap near-term upside. Should Investors Buy, Hold, or Sell ALAB Stock Post Q1 Earnings?
• Neutral Sentiment: Astera Labs’ Q1 2026 earnings transcript kept attention on the company’s strong revenue growth and guidance, but the transcript itself does not add a new catalyst beyond the already reported results. Astera Labs (ALAB) Q1 2026 Earnings Transcript
• Negative Sentiment: The main downside risk is valuation: after a strong run and multiple target hikes, some investors may worry the stock already prices in a lot of future growth.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.